Latest Features

more features >>

NP/PA Practice Corner

CME/CE

Strategies for Improving Outcomes in CAR T-cell Therapy for DLBCL
Activity Type: Linkout

Improving Outcomes in CAR T-cell Therapy for DLBCL | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
1.00 CME CE: Patients with DLBCL face poor outcomes with salvage treatments. CAR T-cell therapy shows promise for patients with relapse after chemoimmunotherapy and ASCT. Exp 10/27/23

More